Latest news with #CharlesPitmanCFA
Business Insider
09-07-2025
- Business
- Business Insider
Barclays Sticks to Its Hold Rating for Ipsen (0MH6)
Barclays analyst Charles Pitman CFA maintained a Hold rating on Ipsen today and set a price target of €110.00. The company's shares closed yesterday at €103.20. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Pitman CFA is a 4-star analyst with an average return of 8.8% and a 52.78% success rate. Pitman CFA covers the Healthcare sector, focusing on stocks such as UCB SA, arGEN X, and Ipsen. Ipsen has an analyst consensus of Moderate Buy, with a price target consensus of €121.71, implying a 17.94% upside from current levels. In a report released on July 7, Kepler Capital also maintained a Hold rating on the stock with a €120.00 price target.
Business Insider
20-06-2025
- Business
- Business Insider
Kepler Capital Keeps Their Hold Rating on Ipsen (0MH6)
In a report released on June 18, Justine Telliez from Kepler Capital maintained a Hold rating on Ipsen (0MH6 – Research Report), with a price target of €120.00. The company's shares closed last Wednesday at €101.70. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Telliez covers the Healthcare sector, focusing on stocks such as Valneva, Genfit, and Adocia SA. According to TipRanks, Telliez has an average return of -9.0% and a 33.68% success rate on recommended stocks. In addition to Kepler Capital , Ipsen also received a Hold from Barclays's Charles Pitman CFA in a report issued on June 11. However, on June 4, Deutsche Bank initiated coverage with a Buy rating on Ipsen (LSE: 0MH6).
Business Insider
02-06-2025
- Business
- Business Insider
Barclays Remains a Buy on UCB SA (0NZT)
Barclays analyst Charles Pitman CFA maintained a Buy rating on UCB SA (0NZT – Research Report) today and set a price target of €240.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Pitman CFA is a 4-star analyst with an average return of 9.2% and a 48.51% success rate. Pitman CFA covers the Healthcare sector, focusing on stocks such as UCB SA, Lonza Group Ltd, and arGEN X. The word on The Street in general, suggests a Strong Buy analyst consensus rating for UCB SA with a €211.00 average price target.
Business Insider
28-04-2025
- Business
- Business Insider
arGEN X (0QW0) Receives a Buy from Barclays
In a report released on April 25, Charles Pitman CFA from Barclays maintained a Buy rating on arGEN X (0QW0 – Research Report), with a price target of €650.00. The company's shares closed last Monday at €352.20. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. According to TipRanks, Pitman CFA is a 4-star analyst with an average return of 9.3% and a 52.81% success rate. Currently, the analyst consensus on arGEN X is a Strong Buy with an average price target of €681.13, which is a 93.39% upside from current levels. In a report released on April 20, Bank of America Securities also maintained a Buy rating on the stock with a €680.00 price target. The company has a one-year high of €656.80 and a one-year low of €324.30. Currently, arGEN X has an average volume of 13.3K.
